Search

Search Constraints

You searched for: Author/Creator Porstner, Martina

Search Results

1. A randomized trial of everolimus‐based quadruple therapy vs standard triple therapy early after lung transplantation. Issue 6 (5th February 2019)

3. Comparing everolimus‐based immunosuppression with reduction or withdrawal of calcineurin inhibitor reduction from 6 months after heart transplantation: The randomized MANDELA study. Issue 11 (5th April 2019)

5. Effect of everolimus‐based drug regimens on CMV‐specific T‐cell functionality after renal transplantation: 12‐month ATHENA subcohort‐study results. Issue 4 (28th December 2020)

6. Efficacy and safety of conversion from cyclosporine to everolimus in living‐donor kidney transplant recipients: an analysis from the ZEUS study. (20th August 2014)

7. Five‐year outcomes in kidney transplant patients randomized to everolimus with cyclosporine withdrawal or low‐exposure cyclosporine versus standard therapy. Issue 12 (3rd June 2018)

8. MiR‐148a is upregulated by Twist1 and T‐bet and promotes Th1‐cell survival by regulating the proapoptotic gene Bim. Issue 4 (22nd January 2015)

9. MiR‐148a promotes plasma cell differentiation and targets the germinal center transcription factors Mitf and Bach2. Issue 4 (12th March 2015)